Provided by Tiger Trade Technology Pte. Ltd.

LONGBIO-B

114.900
-1.500-1.29%
Volume:27.65K
Turnover:3.19M
Market Cap:8.77B
PE:-31.77
High:118.100
Open:114.700
Low:111.700
Close:116.400
52wk High:165.900
52wk Low:72.650
Shares:76.32M
HK Float Shares:75.06M
Volume Ratio:0.35
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-3.617
ROE:--
ROA:-54.56%
PB:53.48
PE(LYR):-31.77
PS:- -

Loading ...

Company Profile

Company Name:
LONGBIO-B
Exchange:
SEHK
Establishment Date:
2020
Employees:
85
Office Location:
Building F, Area A,5th Floor,No. 128 Yinhe Road,Dongnan Subdistrict,Changshu,Jiangsu Province,China
Zip Code:
215500
Fax:
- -
Introduction:
LongBio Pharma (Suzhou) Co Ltd is a China-based company primarily engaged in the in-house discovery and development of biopharmaceuticals targeting allergic and autoimmune diseases. The Company's research and development platforms mainly include High-Affinity Antibody Discovery Platform and Bi-functional Antibody Development Platform. The Company's drug treatment direction mainly includes seasonal allergic rhinitis (AR), chronic spontaneous urticaria (CSU), allergic asthma, food allergy and other allergic diseases, also paroxysmal nocturnal hemoglobinuria (PNH), complement-mediated kidney diseases, which includes IgA nephropathy (IgAN), C3 glomerulopathy (C3G) and lupus nephritis (LN) and other complement related indications. The Company mainly operates its businesses in the domestic market.

Directors

Name
Position
LIU Heng
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
SUN Nai Chao
Executive Director
XIE Ming
Executive Director,Member of the Remuneration and Assessment Committee
LIN Jian
Director,Member of the Audit Committee
GU Qin
Director,Member of the Nomination Committee
XUE Di
Director
CHEN Kan
Director
XIAO Yao Xi
Independent Director,Member of the Nomination Committee,Chairman of the Audit Committee
RUAN Tian Shi
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Audit Committee
YANG Chun
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
ZHOU Guo Fang
Independent Director,Member of the Nomination Committee

Shareholders

Name
Position
LIU Heng
CEO,General Manager
XIE Ming
Vice General Manager
WENG Mei Yi
Corporate Secretary